Liraglutide's influence on food reward and brain function explored in healthy volunteers via fMRI

Obesity and food choices are complex, with GLP-1 mimetics demonstrating anorexic effects beyond DPP-4 inhibitors. While animal studies suggest changes in food preferences, the precise central nervous system mechanisms in humans remain unclear. Functional magnetic resonance imaging (fMRI) offers a valuable tool to observe brain responses to food stimuli, providing insight into reward pathways. Understanding how GLP-1 mimetics like liraglutide modulate these responses could reveal novel therapeutic targets for weight management.

This study aimed to investigate the effects of liraglutide compared to placebo on food choices and brain function in healthy volunteers. Participants underwent fMRI scans to assess brain region responses to visual presentations of preferred, non-preferred, and non-food items. The study design involved a comparison between liraglutide and placebo, focusing on changes in both behavioral food choices and neural activity patterns. Specific dosing and duration details for liraglutide were not provided in the abstract.

The abstract explicitly states that the aim of this study is to "search for possible effects" and that "Findings of this study will help...". Therefore, the abstract does not present any actual results or numerical data from the investigation. No specific changes in food choices, brain function, or statistical outcomes are reported.